Topiramate Tablet, Film Coated
Product Images NDC 71335-1064

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 71335-1064). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

A3c0c9f1 34be 43b2 A33a Bda648fa93d2 01

FDA Label Image

A3c0c9f1 34be 43b2 A33a Bda648fa93d2 02

This text provides data on cumulative rates for time to first seizure comparing two groups of patients taking different dosages of topiramate (50 mg/day and 400 mg/day). The results show a significant difference with a p-value of 0.00002. The graph displays the time in days on the x-axis and cumulative rates on the y-axis.*

FDA Label Image

A3c0c9f1 34be 43b2 A33a Bda648fa93d2 03

FDA Label Image

A3c0c9f1 34be 43b2 A33a Bda648fa93d2 19 2

FDA Label Image

Label Image (Lbl713351064)

This text provides information about a package containing Topiramate 50mg tablets in white and round form. The tablets are stored at room temperature (20°-25°C or 68°-77°F). The package contains 30 tablets and includes the NDC code 7133510641 and expiration date MM/YY. The tablets are compared to Topamax 50mg tablets produced by Unichem Laboratories Ltd. The packaging was done by Bryant Ranck Prepack Bunbauk.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.